SCHEMBL14543795

SCHEMBL14543795

C=C(Oc1ccc(Oc2ccc([N+](=O)[O-])c(C#N)c2)cc1C)C(=O)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 3/20 0.36
MEN1 O00255 1/20 0.36
THRB P10828 1/20 0.36
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
SCN9A Q15858 1/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
USP10 Q14694 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14543905 0.84 MEN1 (0.39) LMNAMAPTALDH1A1KDM4EKMT2A
SCHEMBL4615019 0.80 FBP1 (0.52) LMNAMAPT
SCHEMBL11475898 0.73 MERTK (0.48) MAPTALDH1A1KDM4ETDP1KMT2A
SCHEMBL14289625 0.72 MAPT (0.41) LMNAMAPTALDH1A1TDP1KMT2A
SCHEMBL4616234 0.72 FBP1 (0.51) LMNAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL9229730 0.71 ALDH1A1 (0.46) LMNAMAPTALDH1A1KDM4ETDP1
Hydroquinone SCHEMBL11475895 0.71 EGFR (0.44) LMNAMAPTALDH1A1KDM4ETDP1
SCHEMBL404515 0.69 ALDH1A1 (0.48) LMNAMAPTALDH1A1KDM4ETDP1
SCHEMBL1028021 0.69 MEN1 (0.47) LMNAMAPTKDM4EKMT2AMEN1
SCHEMBL1334205 0.68 KDM4E (0.47) MAPTALDH1A1KDM4ETDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082907-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD LMNA 2712/4885MAPT 3161/4885ALDH1A1 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.